We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to effectively making use of that data.
Companies are influencers and we’re all followers now. This is an evolution that goes all the way back to the 90s.
LinkedIn, the social platform where people look for and talk about work, may be less visible in Microsoft’s earnings compared to the years when it was an
Build your LinkedIn newsletter for success, with 5 key steps that secure subscribers. Level up your LinkedIn presence and business before everyone else catches on.
The political circus may have been in town in D.C. this week with a host of contentious hearings for a series of President Trump’s Cabinet nominees, but it was also down in Florida where Trump was hosting a GOP retreat at his Doral golf course.
A federal court in Texas issued an injunction to keep a woman from distributing revenge porn of her ex-boyfriend online after she allegedly sent an explicit photo of him to his prospective employer over LinkedIn,
LinkedIn became my guide as I transitioned through various industries—from the military to cybersecurity, then data analytics.
LinkedIn is facing a class-action lawsuit over allegations of using private messages to train its AI model.
Sharing isn’t always caring, which might seem to be the case in a lawsuit in which LinkedIn was accused of sharing users’ private messages with other companies to train AI models in August of last year, according to the BBC. A LinkedIn Premium user files the lawsuit in California and on behalf of “all others” in the same situation.
LinkedIn’s latest marketing jobs report highlights industry growth, key skills, and strategies for career success.
As Carroll mentioned before, think of the Canaan Valley as a bathtub. During a clear and cold night with no wind, the warm air rises and escapes to space while the dense cold air pools into the valley, as if turning on the faucet. As with a typical bathtub, the only place for that water to go would be through the drain (Blackwater Canyon).
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It is now FDA-approved to treat moderate to severe acute pain, which is usually caused by injury, trauma or surgery.